Countstar


ALIT Life Science at the AACR Annual 111th Annual Meeting 2019

Atlanta, Georgia World Congress Center, 30th of March to 3rd of April
AACR Annual 111th Annual Meeting 2019

ALIT Life Science presented its latest innovations on the exhibition of the 111th Annual Meeting of the American Association of Cancer Research (AACR) in Atlanta, Georgia. More than 20,000 delegates had the chance to inform themselves at booth # 4631 about the wide range of applications for the Countstar® Rigel and the Countstar® Altair analyser systems in cancer research and biopharmaceutical production.

AACR Annual 111th Annual Meeting 2019

Guests from more than 65 countries were invited to get an overview about the product portfolio of ALIT Life Science.

AACR Annual 111th Annual Meeting 2019

The contribution of ALIT Life Science in CAR-T cell therapy research, obtained with the top model Countstar® Rigel S6, were one of the highlights presented at the booth. ALIT Life Science received a significant amount of requests for performing evaluations of the Countstar® Rigel analyser, and new candidates showed serious interest for a distribution partnership to expand the network of ALIT Life Science globally.

AACR Annual 111th Annual Meeting 2019
Related News
  • JoVE:Stem cell “3D” technologyJune 18, 2019

    JoVE:Stem cell “3D” technology

    Stem cells are important for repairing damaged tissues and organs. Because stem cells can develop into any type of cell in the body, scientists believe they hold the key to groundbreaking new treatmen...view
  • Human stem cells may produce 'artificial blood'May 16, 2019

    Human stem cells may produce 'artificial blood'

    Scientists are using stem cells to create artificial blood that will be tested in the UK in two years. The scientists that are doing the research believe it could change the way blood transfusions are...view
  • Stem cell therapy may cure Parkinson's diseaseMay 16, 2019

    Stem cell therapy may cure Parkinson's disease

    Researchers used stem cells from human embryos to successfully treat Parkinson's disease in mice and rats. This is a key step in finding similar treatments for humans.In a study published on this sund...view